State of the art research and development and pre-clinical and clinical trials for Prolon® were conducted at the University of Southern California’s Longevity Institute and Diabetes and Obesity Research Institute, and sponsored by the National Cancer Institutes (NCI) and National Institute on Aging (NIA) of the National Institute of Health (NIH).
The results of the above research were published in top scientific peer-reviewed journals.
A Periodic Diet that Mimics Fasting Promotes MultiSystem Regeneration, Enhanced Cognitive Performance, and Healthspan
Science and Translational Medicine
Fasting-mimicking diet and markers/risk factors for aging, diabetes, cancer, and cardiovascular disease
Fasting: Molecular Mechanisms and Clinical Applications
Low Protein Intake Is Associated with a Major Reduction in IGF-1, Cancer, and Overall Mortality in the 65 and Younger but Not Older Population
Can a Diet That Mimics Fasting Turn Back the Clock?
Enhancing Stem Cell Transplantation with ‘‘Nutri-technology’’
Association of Animal and Plant Protein Intake With All-Cause and Cause-Specific Mortality
The ingredients in ProLon are considered generally recognized as safe (GRAS). ProLon is not intended to diagnose, treat, cure or prevent any diseases and has not been evaluated as such by the FDA.
Enter it here and continue.
No code? Just click continue.
Please Enter HCP Code:
Your feedback has been received.